Jörgen Gustafsson

Title: Jörgen Gustafsson: Innovator in Chemokine Receptor Modulation

Introduction

Jörgen Gustafsson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate chemokine receptor activity. His work is essential for advancing therapeutic options in various medical conditions.

Latest Patents

Gustafsson holds a patent for "Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity." This invention provides compounds of general formula (I), which are defined in the specification. The patent outlines processes for their preparation, pharmaceutical compositions containing these compounds, and their therapeutic uses. He has 1 patent to his name.

Career Highlights

Jörgen Gustafsson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical industry. His expertise in chemokine receptor modulation is particularly noteworthy.

Collaborations

Gustafsson has collaborated with talented individuals such as Nafizal Hossain and Stinabritt Nilsson. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Jörgen Gustafsson's work in the field of chemokine receptor modulation exemplifies the impact of innovative research on therapeutic advancements. His contributions continue to influence the pharmaceutical landscape positively.